EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

NADH Reductive Stress and Its Correlation with Disease Severity in Leigh Syndrome: A Pilot Study Using Patient Fibroblasts and a Mouse Model

Tamaki Ishima iD, Natsuka Kimura, Mizuki Kobayashi, Chika Watanabe, Eriko F Jimbo, Ryosuke Kobayashi iD, Takuro Horii, Izuho Hatada, Kei Murayama, Akira Ohtake iD, Ryozo Nagai, Hitoshi Osaka iD und 1 weitere

Biomolecules · 2024

DOI: 10.3390/biom15010038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Tamaki Ishima und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Shimotsuke 329-0498, Japan. Hauptthemen laut MEDLINE: Leigh Disease, NAD, Fibroblasts. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (AMED), Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) fro….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nicotinamide adenine dinucleotide (NAD) is a critical cofactor in mitochondrial energy production. The NADH/NAD+ ratio, reflecting the balance between NADH (reduced) and NAD+ (oxidized), is a key marker for the severity of mitochondrial diseases. We recently developed a streamlined LC-MS/MS method for the precise measurement of NADH and NAD+. Utilizing this technique, we quantified NADH and NAD+ levels in fibroblasts derived from pediatric patients and in a Leigh syndrome mouse model in which mitochondrial respiratory chain complex I subunit Ndufs4 is knocked out (KO). In patient-derived fibroblasts, NAD+ levels did not differ significantly from those of healthy controls (p = 0.79); however, NADH levels were significantly elevated (p = 0.04), indicating increased NADH reductive stress. This increase, observed despite comparable total NAD(H) levels between the groups, was attributed to elevated NADH levels. Similarly, in the mouse model, NADH levels were significantly increased in the KO group (p = 0.002), further suggesting that NADH elevation drives reductive stress. This precise method for NADH measurement is expected to outperform conventional assays, such as those for lactate, providing a simpler and more reliable means of assessing disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leigh DiseaseNADFibroblastsAnimalsMiceDisease Models, AnimalHumansPilot ProjectsElectron Transport Complex IFemaleMaleMice, KnockoutChildOxidation-ReductionChild, Preschool

Stichwörter der Autor:innen

LC-MS/MSLeigh syndromeNADHNdufs4-KO micemitochondrial diseasesreductive stress

Substanzen

NADElectron Transport Complex INdufs4 protein, mouseNDUFS4 protein, human

Autor:innen und Institutionen

  • Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Shimotsuke 329-0498, Japan.
  • Department of Pediatrics, Jichi Medical University, Shimotsuke 329-0498, Japan.
  • Biosignal Genome Resource Center, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi 371-8512, Japan.
  • Viral Vector Core, Gunma University Initiative for Advanced Research (GIAR), Maebashi 371-8511, Japan.
  • Center for Medical Genetics, Chiba Children's Hospital, Chiba 266-0007, Japan.
  • Diagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, Tokyo 113-8431, Japan.

ORCID-Profile: Tamaki Ishima, Ryosuke Kobayashi, Akira Ohtake, Hitoshi Osaka

Förderung

  • Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (AMED)
  • Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) fro…

Zitieren

APA

Ishima, T., Kimura, N., Kobayashi, M., Watanabe, C., Jimbo, E. F., Kobayashi, R., Horii, T., Hatada, I., Murayama, K., Ohtake, A., Nagai, R., Osaka, H., & Aizawa, K. (2024). NADH Reductive Stress and Its Correlation with Disease Severity in Leigh Syndrome: A Pilot Study Using Patient Fibroblasts and a Mouse Model. Biomolecules. https://doi.org/10.3390/biom15010038

Vancouver

Ishima T, Kimura N, Kobayashi M, Watanabe C, Jimbo EF, Kobayashi R, et al. NADH Reductive Stress and Its Correlation with Disease Severity in Leigh Syndrome: A Pilot Study Using Patient Fibroblasts and a Mouse Model. Biomolecules. 2024. doi:10.3390/biom15010038

BibTeX
@article{Ishima2024,
  author = {Ishima, Tamaki and Kimura, Natsuka and Kobayashi, Mizuki and Watanabe, Chika and Jimbo, Eriko F and Kobayashi, Ryosuke and Horii, Takuro and Hatada, Izuho and Murayama, Kei and Ohtake, Akira and Nagai, Ryozo and Osaka, Hitoshi and Aizawa, Kenichi},
  title = {NADH Reductive Stress and Its Correlation with Disease Severity in Leigh Syndrome: A Pilot Study Using Patient Fibroblasts and a Mouse Model},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom15010038}
}
Kostenlos starten →